Antimicrobial resistance as a social dilemma: Approaches to reducing broad-spectrum antibiotic use in acute medical patients internationally

抗生素耐药性是一个社会困境:国际上减少急性内科患者广谱抗生素使用的方法

基本信息

  • 批准号:
    ES/P004784/1
  • 负责人:
  • 金额:
    $ 26.09万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2017
  • 资助国家:
    英国
  • 起止时间:
    2017 至 无数据
  • 项目状态:
    已结题

项目摘要

Antimicrobial resistance is one of the largest and most widely-acknowledged problems in 21st century medicine. Attempts to change the ways antibiotics are prescribed, in order to tackle the problem of antimicrobial resistance, have met with variable success. This is partly because the prescription of antibiotics is influenced by many social, cultural and organisational factors, and those prescribing antibiotics have to balance competing interests, values and short and long term benefits when making decisions. Healthcare providers have a responsibility both to individual patients and to "society at large", and since there is often not a "technical" solution to problems with prescribing, decisions are usually based on moral values and the customs of the healthcare community. Therefore attempts to change the ways antibiotics are prescribed will be more effective if they take these social factors into account. These social factors, and thus decisions made by individuals about prescribing antibiotics, are strongly influenced by the local and national context. By comparing attitudes to prescribing antibiotics in England, Sri Lanka, and South Africa this study will consider and predict the influence of different contextual factors on various attempts to change the ways antibiotics are prescribed. This will make it easier to assess which attempts will be successful and could be repeated in different international contexts. Models, which take these factors into account, can be used to predict how changes in individual behaviour, social, cultural, or economic factors will impact on decisions about prescribing antibiotics, and the broader problem of antimicrobial resistance. The project has three main aims:1. To develop an international group of academics and clinicians who will work together to use social science theory and methods to look at the use of antibiotics in treating seriously ill patients. Close collaboration will make sure that the work of the project will be relevant to many contexts in which people are trying to improve antimicrobial resistance, particularly in non-high income countries. 2. To use theory to build a model that describes the use of broad spectrum antibiotics in treating seriously ill patients. The model will identify the risks, tensions, and elements of social and cultural context that effect the way antibiotics are prescribed. To find ways to improve antibiotic prescribing, and to consider the potential of various actions to address problems with the use of antibiotics in treating seriously ill patients in different parts of the world. 3. To begin work on a future proposal which would use two types of mathematical models to predict the effect of various attempts to try and improve the use of antibiotics in different contexts. The model or models developed within the grant could be used to improve the success of attempts to influence antibiotic prescription, by making it clearer which actions have the best chance of success in different contexts, particularly in non-high income countries. This would reduce the risk of investing finances, time, and energy in unsuccessful projects. The work will lay the ground work for future international collaborations, and for the development of larger projects to research and test attempts to improve the way antibiotics are prescribed. This might involve a study which interviews patients to explore their role in the prescription of antibiotics. The study will also involve training local researchers in Sri Lanka and South Africa in interviewing skills
抗菌药物耐药性是21世纪世纪医学中最大和最广泛认识的问题之一。为了解决抗生素耐药性问题,试图改变抗生素的处方方式,取得了不同的成功。这部分是因为抗生素的处方受到许多社会,文化和组织因素的影响,处方抗生素的人在做出决定时必须平衡相互竞争的利益,价值观以及短期和长期利益。医疗服务提供者对患者个人和“整个社会”都负有责任,由于处方问题通常没有“技术”解决方案,因此决策通常基于道德价值观和医疗保健社区的习俗。因此,如果考虑到这些社会因素,尝试改变抗生素处方的方式将更加有效。这些社会因素,以及个人对抗生素处方的决定,受到当地和国家背景的强烈影响。通过比较在英国,斯里兰卡和南非处方抗生素的态度,本研究将考虑和预测不同的背景因素对各种尝试改变抗生素处方的影响。这将使人们更容易评估哪些尝试将取得成功,哪些尝试可以在不同的国际环境中重复。考虑到这些因素的模型可用于预测个人行为,社会,文化或经济因素的变化将如何影响处方抗生素的决定,以及更广泛的抗菌素耐药性问题。该项目有三个主要目标:1。建立一个由学者和临床医生组成的国际小组,他们将共同努力,利用社会科学理论和方法来研究抗生素在治疗重病患者中的使用。密切合作将确保该项目的工作与人们试图改善抗菌素耐药性的许多情况相关,特别是在非高收入国家。2.用理论建立一个模型,描述广谱抗生素在治疗重症患者中的应用。该模型将确定影响抗生素处方方式的风险,紧张局势以及社会和文化背景因素。寻找改善抗生素处方的方法,并考虑各种行动的潜力,以解决世界各地使用抗生素治疗重病患者的问题。3.开始研究一项未来提案,该提案将使用两种数学模型来预测在不同情况下尝试和改进抗生素使用的各种尝试的效果。在赠款范围内开发的一个或多个模型可用于提高影响抗生素处方的尝试的成功率,方法是使人们更清楚地了解在不同情况下,特别是在非高收入国家,哪些行动最有可能取得成功。这将减少在不成功的项目上投入资金、时间和精力的风险。这项工作将为未来的国际合作奠定基础,并为开发更大的项目,以研究和测试改善抗生素处方方式的尝试奠定基础。这可能涉及一项研究,该研究采访了患者,以探索他们在抗生素处方中的作用。这项研究还将涉及培训斯里兰卡和南非的当地研究人员的采访技巧

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Advances in Social Simulation - Looking in the Mirror
社交模拟的进展 - 照镜子
  • DOI:
    10.1007/978-3-030-34127-5_9
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Chattoe-Brown E
  • 通讯作者:
    Chattoe-Brown E
Drivers of Broad-Spectrum Antibiotic Overuse across Diverse Hospital Contexts-A Qualitative Study of Prescribers in the UK, Sri Lanka and South Africa.
  • DOI:
    10.3390/antibiotics10010094
  • 发表时间:
    2021-01-19
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tarrant C;Colman AM;Jenkins DR;Chattoe-Brown E;Perera N;Mehtar S;Nakkawita WMID;Bolscher M;Krockow EM
  • 通讯作者:
    Krockow EM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carolyn Tarrant其他文献

The Prostate Care Questionnaire for Patients (PCQ-P): Reliability, validity and acceptability
  • DOI:
    10.1186/1472-6963-9-199
  • 发表时间:
    2009-11-04
  • 期刊:
  • 影响因子:
    3.000
  • 作者:
    Carolyn Tarrant;Richard Baker;Andrew M Colman;Paul Sinfield;Shona Agarwal;John K Mellon;William Steward;Roger Kockelbergh
  • 通讯作者:
    Roger Kockelbergh
Correction: Organizational resilience in healthcare: a review and descriptive narrative synthesis of approaches to resilience measurement and assessment in empirical studies
  • DOI:
    10.1186/s12913-023-09636-9
  • 发表时间:
    2023-07-05
  • 期刊:
  • 影响因子:
    3.000
  • 作者:
    Agnieszka Ignatowicz;Carolyn Tarrant;Russell Mannion;Dena El‑Sawy;Simon Conroy;Daniel Lasserson
  • 通讯作者:
    Daniel Lasserson
Indispensable yet invisible: A qualitative study of the roles of carers in infection prevention in a South Indian hospital
  • DOI:
    10.1016/j.ijid.2022.08.011
  • 发表时间:
    2022-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Surya Surendran;Enrique Castro-Sánchez;Vrinda Nampoothiri;Shiny Joseph;Sanjeev Singh;Carolyn Tarrant;Alison Holmes;Esmita Charani
  • 通讯作者:
    Esmita Charani
The impact of long COVID on UK healthcare workers and their workplace: a qualitative study of healthcare workers with long COVID, their families, colleagues and managers
  • DOI:
    10.1186/s12913-025-12677-x
  • 发表时间:
    2025-04-09
  • 期刊:
  • 影响因子:
    3.000
  • 作者:
    Amani Al-Oraibi;Carolyn Tarrant;Katherine Woolf;Laura B. Nellums;Manish Pareek
  • 通讯作者:
    Manish Pareek
Prosociality in the social dilemma of antibiotic prescribing
抗生素处方社会困境中的亲社会行为
  • DOI:
    10.1016/j.copsyc.2021.09.007
  • 发表时间:
    2022-04-01
  • 期刊:
  • 影响因子:
    6.900
  • 作者:
    Eva M. Krockow;Carolyn Tarrant;Andrew M. Colman
  • 通讯作者:
    Andrew M. Colman

Carolyn Tarrant的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

Naringin通过改善Leptin Resistance调节肠上皮AQP3重建糖脂代谢平衡的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
  • 批准号:
    82372275
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
  • 批准号:
    82371873
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
  • 批准号:
    82372203
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
SUCLA2失调控介导的琥珀酸代谢异常促进巨噬细胞炎性活化及肥胖发生
  • 批准号:
    32000525
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
PRMT1-meFOXO1通路在低温常压等离子体诱导的三阴型乳腺癌细胞铁死亡中的作用机制研究
  • 批准号:
    31900528
  • 批准年份:
    2019
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目
去唾液酸糖蛋白受体1(ASGR1)调控脂质转运的分子机制及其在非酒精性脂肪肝炎中的作用研究
  • 批准号:
    31900539
  • 批准年份:
    2019
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
ISLR参与肥胖小鼠胰岛素抵抗的机制研究
  • 批准号:
    31970712
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
RND驱动重金属外排泵介导的细菌性果斑病菌抗铜机制及其调控机理研究
  • 批准号:
    31560498
  • 批准年份:
    2015
  • 资助金额:
    39.0 万元
  • 项目类别:
    地区科学基金项目
地塞米松诱导的人卵巢癌对化疗药物耐受及其机制的研究
  • 批准号:
    81172471
  • 批准年份:
    2011
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

Quantifying the Use of Epidemiologic Treatment and its Role in the Development of Antimicrobial-Resistant N. gonorrhoeae among Men who have Sex with Men (MSM)
量化流行病学治疗的使用及其在男男性行为者 (MSM) 耐药性淋病奈瑟菌发展中的作用
  • 批准号:
    10312821
  • 财政年份:
    2020
  • 资助金额:
    $ 26.09万
  • 项目类别:
Real-time genomic surveillance of antimicrobial resistance to guide robust infection control practices
抗菌药物耐药性的实时基因组监测以指导强有力的感染控制实践
  • 批准号:
    429143
  • 财政年份:
    2019
  • 资助金额:
    $ 26.09万
  • 项目类别:
    Studentship Programs
Antimicrobial Resistance Transmission Associated with Small-Scale Food-Animal Production in Peri-Urban Communities of Quito, Ecuador
厄瓜多尔基多城郊社区小规模食用动物生产相关的抗生素耐药性传播
  • 批准号:
    9922861
  • 财政年份:
    2018
  • 资助金额:
    $ 26.09万
  • 项目类别:
Social-Cultural Approaches to Microbial Life in an Era of Antimicrobial Resistance
抗菌素耐药性时代微生物生命的社会文化方法
  • 批准号:
    ES/S011595/1
  • 财政年份:
    2018
  • 资助金额:
    $ 26.09万
  • 项目类别:
    Fellowship
A Population-Level Analysis of Novel Antimicrobial Production Among Wild Marine V
野生海洋 V 中新型抗菌剂生产的群体水平分析
  • 批准号:
    8433969
  • 财政年份:
    2013
  • 资助金额:
    $ 26.09万
  • 项目类别:
Antimicrobial catheter
抗菌导管
  • 批准号:
    8122452
  • 财政年份:
    2011
  • 资助金额:
    $ 26.09万
  • 项目类别:
Distribution of the Costs of Antimicrobial Resistant Infections
抗菌素耐药性感染的成本分布
  • 批准号:
    7633315
  • 财政年份:
    2007
  • 资助金额:
    $ 26.09万
  • 项目类别:
Distribution of the Costs of Antimicrobial Resistant Infections
抗菌素耐药性感染的成本分布
  • 批准号:
    7825410
  • 财政年份:
    2007
  • 资助金额:
    $ 26.09万
  • 项目类别:
Distribution of the Costs of Antimicrobial Resistant Infections
抗菌素耐药性感染的成本分布
  • 批准号:
    7503500
  • 财政年份:
    2007
  • 资助金额:
    $ 26.09万
  • 项目类别:
Distribution of the Costs of Antimicrobial Resistant Infections
抗菌素耐药性感染的成本分布
  • 批准号:
    7483851
  • 财政年份:
    2007
  • 资助金额:
    $ 26.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了